Political EconomyGovernment & regulators

Cannabis-Hemp Act 2026 Draft Legislation (Thailand)

The Cannabis-Hemp Act of Thailand is draft legislation under parliamentary consideration following the 2024 Pheu Thai-led government's decision to reverse the 2022 decriminalisation policy. The draft Act aims to re-criminalise recreational cannabis use while preserving legal frameworks for medical-use prescriptions, licensed dispensaries, industrial hemp cultivation (under 1 percent THC), and R&D applications. The legislative process has been contested, with the cannabis industry, tourism operators, and medical advocates lobbying for a regulated recreational tier, while public-health and drug-enforcement advocates push for tighter restrictions. The Act's final form will determine the viability of Thailand's cannabis tourism sector, medical-cannabis export potential, and the GACP-certified cultivation industry. Regulatory uncertainty has already caused significant market contraction since late 2023.

Snapshot

Headline numbers a buyer checks first.

Legislative status

Draft; stalled as of Oct 2025

October 2025

Multiple readings; contested by industry and public-health advocates

Key provision: recreational use

Re-criminalised under draft

2025 draft

Industrial hemp THC limit

<1% THC preserved

2025 draft

Industrial hemp exemption maintained in all draft versions

Peak dispensary count (pre-draft)

~6,000–18,000

2022-2023

Registered with Thai FDA at peak; majority closed or non-compliant by 2025

Profile overview

The Cannabis-Hemp Act of Thailand is draft legislation under parliamentary consideration following the 2024 Pheu Thai-led government's decision to reverse the 2022 decriminalisation policy. The draft Act aims to re-criminalise recreational cannabis use while preserving legal frameworks for medical-use prescriptions, licensed dispensaries, industrial hemp cultivation (under 1 percent THC), and R&D applications. The legislative process has been contested, with the cannabis industry, tourism operators, and medical advocates lobbying for a regulated recreational tier, while public-health and drug-enforcement advocates push for tighter restrictions. The Act's final form will determine the viability of Thailand's cannabis tourism sector, medical-cannabis export potential, and the GACP-certified cultivation industry. Regulatory uncertainty has already caused significant market contraction since late 2023.

Public-record references
Data as of: 2024-2026

Key policy segments

Medical cannabis

Licensed medical-use tier

The draft Act preserves Thai FDA-licensed dispensaries for medical-cannabis prescription. An estimated 1,500–2,500 compliant dispensaries would be grandfathered under a tighter regulatory framework with mandatory healthcare-provider oversight.

Industrial hemp

Hemp cultivation under 1% THC

Industrial hemp with THC below 1% is preserved across all draft versions. This protects the hemp-fibre, hemp-seed, and hemp-food export segments from the recreational policy reversal.

GACP cultivation

Good Agricultural and Collection Practices

GACP-certified cultivation for pharmaceutical-grade cannabis is maintained. Thailand's ambition to become a medical-cannabis export hub under GMP licensing depends on GACP supply-chain integrity surviving the legislative process.

Tourism zone

Contested tourist-zone recreational tier

Coalition partners from tourism constituencies have lobbied for a regulated adult-use tier in designated tourist zones (e.g. Phuket, Samui, Pattaya). This provision remains contested and is not in the conservative draft version.

Cannabis-Hemp Act: provision scenarios

Regulatory outcomes by draft version, 2025

Recreational use

Current status (ministerial orders)

Grey-zone tolerated

Draft Act (conservative)

Re-criminalised

Draft Act (tourist-zone tier)

Regulated; licensed zones

Medical dispensary

Current status (ministerial orders)

Thai FDA licence required

Draft Act (conservative)

Maintained; tighter rules

Draft Act (tourist-zone tier)

Maintained; tighter rules

Industrial hemp (<1% THC)

Current status (ministerial orders)

Permitted

Draft Act (conservative)

Preserved

Draft Act (tourist-zone tier)

Preserved

GACP cultivation

Current status (ministerial orders)

Thai FDA certified

Draft Act (conservative)

Maintained

Draft Act (tourist-zone tier)

Maintained

Export (medical)

Current status (ministerial orders)

GPO-only pathway

Draft Act (conservative)

Expanded via GMP licensing

Draft Act (tourist-zone tier)

Expanded via GMP licensing

Tourism cannabis products

Current status (ministerial orders)

Tolerated in grey-zone

Draft Act (conservative)

Banned

Draft Act (tourist-zone tier)

Permitted in designated zones

Draft Cannabis-Hemp Act text; ONCB; Thai FDA policy releases
Data as of: 2025

Watchpoints 2025–2026

Legislative timeline

Act passage and effective date

The draft remains stalled as of October 2025. Each month of delay extends legal grey-zone conditions that deter investment in compliant dispensaries, GACP cultivation, and medical-export licensing.

Tourism lobby

Tourist-zone recreational tier

If Pheu Thai coalition partners from tourism constituencies successfully insert a regulated adult-use zone provision, it would create a bifurcated market: strict national rules with liberalised resort-zone exemptions similar to Thailand's entertainment-venue framework.

Medical export

GMP export licensing development

Thailand's ambition to build a $0.58-30B medical-cannabis export industry requires the Act to establish a clear GMP-export licensing regime. Delay means competitor jurisdictions (Australia, Germany, Malta) capture market share in EU medical channels.

Legislative framework snapshot

Policy reversal

2022 decriminalisation and the rollback

The June 2022 removal of cannabis from Category 5 narcotics created an overnight dispensary boom: 6,000–18,000 shops registered. The Pheu Thai-led government from August 2023 moved to reverse course, with PM Srettha and then PM Paetongtarn signalling recriminalisation.

Market impact

Market contraction under uncertainty

Regulatory uncertainty since late 2023 caused an estimated 70–85% contraction in the dispensary count. GACP cultivator investment halted. Medical tourism operators offering cannabis wellness packages have largely paused pending the Act's final form.

Related Market profiles

Peers, parents, partners, agencies, and other Political Economy actors.

Reports featuring this profile

Related Market profiles

Cannabis-Hemp Act 2026 Draft Legislation (Thailand) - Market Atlas · Insight